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The Protooncogene Ski Controls
Schwann Cell Proliferation and Myelination
Conversely, overexpression of Ski in Schwann cells
causes an upregulation of myelin-related genes. The
myelination-regulating transcription factor Oct6 is in-
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and adult TGF-1-deficient animals have abnormal my-
elin (Day et al., 2003). In most cell types, active TGF-s
bind to heteromeric complexes between type I and type
II TGF- receptors (TR-I, TR-II). TR-I phosphorylates
Smad2 and Smad3. The activated Smad2/3 bind to the
single common Smad4 and translocate to the nucleus
where they interact with other transcription factors and
activate transcription of TGF--responsive genes (Lutz
and Knaus, 2002; Moustakas et al., 2001). Ski represses
TGF- signaling through direct interactions with Smad2,
-3, and -4 (Akiyoshi et al., 1999; Luo et al., 1999; Sun et
al., 1999; Wu et al., 2002; Xu et al., 2000). The mechanism
of Ski-mediated repression has been attributed to the
ability of Ski to recruit the nuclear corepressor (N-CoR)
and the histone deacetylase complex (HDAC) to regula-
tory promoter sequences, thereby modulating gene
transcription (Nomura et al., 1999; Tokitou et al., 1999).
Ski also interferes with the binding of Smads to the
transcriptional coactivator p300/CBP (Akiyoshi et al.,
1999).
We show that Ski is highly and selectively expressed
by myelinating Schwann cells in vivo and induces the
expression of genes encoding myelin proteins. If Ski is
absent, the expression of myelin-related genes is re-
duced and the formation of peripheral myelin is abol-
ished. Thus, Ski is a crucial component of the signaling
machinery regulating PNS myelination.
Results
Ski Is Upregulated by Growth-Arrested
Schwann Cells
To start examining the potential role of Ski in Schwann
cell proliferation and differentiation, we analyzed Ski
expression in growing and growth-arrested Schwann
cells in vitro (Figure 1). In proliferating, Ki-67-positive
cultures (Figure 1Ac, green), Ski was undetectable (Fig- Figure 1. Ski Expression in Purified Rat Schwann Cell Cultures
ure 1Aa, red). In contrast, when Schwann cells were (A) Triple labeling of rapidly growing (Aa and Ac) and growth-arrested
maintained in minimal medium (0.5% fetal calf serum (Ab and Ad) rat Schwann cells. The nuclei of Schwann cells are
[FCS]), they stopped proliferating (Figure 1Ad; no Ki-67 visualized with DAPI ([Aa and Ab], blue). Ki-67 (green) labels prolifer-
ating cells (Ac) but disappears from postmitotic cells (Ad). Ski (red)expression) and concomitantly upregulated Ski in their
is absent in proliferating cells (Aa), whereas nonproliferating cellsnuclei (Figure 1Ab, purple; colocalization with nuclear
show significant amounts of nuclear Ski expression ([Ab], overlayDAPI). Western blot analysis confirmed the expression
with DAPI appears purple). Scale bar, 20 m (in [Ad] for [Aa]–[Ad]).
of Ski in extracts of nonproliferating Schwann cells (Fig- (B) Immunoblot analysis of lysates of proliferating and nonproliferat-
ure 1B). So, upregulation of Ski protein levels correlates ing Schwann cells. Detection with polyclonal anti-Ski antibody.
with growth arrest of cultured Schwann cells. Equal amounts of protein extracts controlled by -actin detection
(lower panel). Positive control: protein extract of rat Schwann cells
transfected with a Ski expression plasmid (lane 3).Ski Specifically Antagonizes TGF-1-Mediated
Schwann Cell Proliferation and Prevents
Reentry into the Cell Cycle
Next, we asked whether Ski has a functional inhibitory The percentage of Ski/BrdU-positive cells was deter-
mined in relation to the total number of Ski-transfectedeffect on Schwann cell proliferation. Thus, we examined
the consequences of forced Ski expression (Figure 2). cells for each culture condition (Figure 2A, gray bars).
Ski-transfected cells, easily identified based on strongSchwann cells were grown under different conditions
promoting proliferation, including Schwann cell medium nuclear Ski expression, did not show significant cell
death (data not shown). Parallel cultures were trans-containing 10% FCS, glial growth factor (GGF), and for-
skolin, or in minimal media containing 0.5% FCS supple- fected with a control plasmid expressing enhanced
green fluorescent protein (EGFP), and the percentagemented with the Schwann cell mitogens GGF (Lemke
and Brockes, 1984) or TGF-1 (Ridley et al., 1989), or of EGFP/BrdU-double-positive cells in relation to the
total number of EGFP-transfected cells was calculatedbasic fibroblast growth factor (bFGF; Davis and Stroo-
bant, 1990). Cells were transiently transfected with a (Figure 2A, black bars). First, this analysis revealed dif-
ferent proliferation rates under different growth condi-Ski-expression vector, and 48 hr later, proliferating cells
were labeled with bromodeoxyuridine (BrdU) for 16 hr. tions (Figure 2A, compare black bars). More importantly,
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transgenic expression of Ski specifically inhibited prolif-
eration mediated by TGF-1 (Figures 2A and 2B) but
had no effect on GGF- or bFGF-mediated proliferation.
In addition, Ski also significantly decreased the prolifera-
tion rate of Schwann cells in medium containing 10%
FCS. These data indicate a specific antagonistic func-
tion of Ski in TGF-1-mediated Schwann cell prolifer-
ation.
To investigate whether exogenous Ski-expressing
cells are able to reenter the cell cycle after addition of
growth factors, parallel cultures were transfected with
a Ski or an EGFP expression vector and maintained
for 3 days in minimal medium containing 0.5% FCS to
achieve growth arrest (Figure 2C). Subsequently, the
cells were reinduced to proliferate by adding various
proliferation-promoting media, including Schwann cell
medium containing 10% FCS or minimal media supple-
mented with GGF, TGF-1, or bFGF. Cells were cultured
for an additional 2 days, and the percentage of dividing
cells was determined by BrdU incorporation for 16 hr.
Regardless of the growth-promoting media tested, a
significantly lower number of exogenous Ski-expressing
cells reentered the cell cycle (Figure 2C, gray bars) com-
pared to EGFP-expressing cells (Figure 2C, black bars).
Thus, Ski overexpression blocks Schwann cells from
reentering the cell cycle, irrespective of the growth fac-
tors used to induce proliferation.
TGF-1 Prevents Ski Expression
in Myelinating Cocultures
Our findings suggested that Ski was expressed and
functional in growth-arrested rather than in proliferating
Schwann cells. Given the interconnection of cell cycle
exit and differentiation in Schwann cells, we tested
whether Ski expression was induced by neurons and by
subsequent myelination. The model of Schwann cells
cocultured with dorsal root ganglion (DRG) neurons fol-
lowed by the induction of myelination with ascorbic acid
and progesterone provides an excellent experimental
setting to examine these questions (Eldridge et al., 1987;
Notterpek et al., 1999). In the absence of myelination-
promoting factors, such cocultures showed very low
expression of myelin-associated glycoprotein (MAG)
(Figures 3Aa and 3Ad, red) and no detectable expression
of Ski by immunofluorescence analysis (Figures 3Aa andFigure 2. Ski Regulates Schwann Cell Proliferation
3Ad, green). Upon induction of myelination, myelinated
Ski inhibits TGF-1-mediated Schwann cell proliferation (A and B)
internodes were prominent as visualized by anti-MAGand prevents Schwann cells from reentering the cell cycle (C). (A)
antibody stainings (Figures 3Ab and 3Ae, red). Ski wasQuantitative analysis of proliferation rates of Ski-expressing and
control EGFP-expressing Schwann cells grown under different con- highly upregulated in the nuclei of Schwann cells (Fig-
ditions. Control-transfected Schwann cells (black bars) showed the ures 3Ab and 3Ae), independent of whether Schwann
highest proliferation rate when cultured in Schwann cell medium cells were myelinating an axonal segment (arrowheads)
containing 10% FCS, 100 g/ml crude GGF, and 2 M forskolin. or not. Interestingly, upregulation of Ski was not found
The proliferation rate was lowest in minimal medium containing 0.5%
in pure Schwann cell cultures treated with ascorbic acidFCS with no additional growth factors. Addition of recombinant GGF
or TGF-1 or bFGF to minimal medium led to an increase in the
percentage of BrdU-labeled nuclei. Overexpression of Ski specifi-
cally decreased the proliferation capacity of cells grown in the pres-
ence of TGF-1 or in Schwann cell medium (gray bars). Data are the overlay). Scale bar in Bb (for Ba and Bb), 10 m. (C) Quantitative
mean values of three experiments SD. Student’s t tests were ap- analysis of proliferation rates of Ski- and control EGFP-expressing
plied to test for significance: **p  0.01, ***p  0.005. (B) Triple Schwann cells induced to divide by different mitogens. Under all
immunostaining of a representative Ski-transfected culture grown conditions tested, exogenous Ski-expression significantly de-
in minimal medium supplemented with 0.5% FCS and TGF-1. (Ba) creased the capacity of Schwann cells to proliferate (gray bars),
DAPI, blue; DAPI/BrdU, greenish blue; (Bb) BrdU, green; Ski, red. compared to control EGFP-expressing cells (black bars). Data: mean
Arrows in (Bb) indicate selected Ski-expressing cells; the arrowhead values of three experiments SD. Student’s t test was applied to
points to a cell that is double positive for Ski and BrdU (yellow in test for significance: *p  0.05, **p  0.01, ***p  0.005.
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Figure 3. Ski Is Upregulated in DRG-Schwann Cell Cocultures under Myelinating Conditions
(A) Schwann cell/DRG neuron cocultures were grown for 14 days in control media that did not allow myelin formation (Aa and Ad) or in myelin-
promoting media without (Ab and Ae) or with TGF-1 (Ac and Af). Cocultures were fixed and triple stained for Ski ([Aa–Af], green), the myelin
marker MAG ([Aa–Af], red), and with nuclear DAPI ([Ad–Af], blue). In nonmyelinating cocultures, Ski expression was undetectable (Aa), whereas
Ski was upregulated in myelinating cocultures (Ab) and localized to the Schwann cell nuclei ([Ae], overlay with DAPI appears greenish blue).
TGF-1 prevented Ski expression (Ac). Scale bar, 10 m (in [Af] for [Aa]–[Af]).
(B) Immunoblot analysis of lysates from nonmyelinating and myelinating cocultures. The membrane was probed with a polyclonal anti-Ski
antibody. Multiple isoforms of Ski range from 90 kd to 110 kd. The myelin marker MAG is upregulated during myelination. Equal amounts of
protein extract controlled by -actin detection.
and/or progesterone (data not shown). These findings 4A, gray bars) or in the adult (P64, gray bar). Ski tran-
script levels also remained unaffected 4 days after nerveindicate that the presence of neurons, in combination
injury, when Schwann cells are highly proliferative (Fig-with a myelination-promoting environment, is required
ure 4B, gray bars). To assess the levels of Ski protein,for triggering Ski induction. Western blot analysis con-
we carried out Western blotting analysis using Schwannfirmed the upregulation of Ski under myelin-promoting
cell nuclear extracts from developing sciatic nerves atconditions (Figure 3B).
P0 (Figure 4C, lane 1) and P90 (Figure 4C, lane 2). InTGF-1 prevents the differentiation of Schwann cells
contrast to the mRNA levels, the Ski protein level wastoward the myelinating phenotype (Einheber et al.,
strongly increased in differentiated (P90) compared to1995). Based on our data and the described antagonistic
immature and proliferating Schwann cells (P0). Further-role of Ski in TGF-1 signaling in other cell types (Akiy-
more, Ski protein levels were downregulated 4 days postoshi et al., 1999; Luo et al., 1999; Sun et al., 1999; Xu
nerve transection (4dpT), when Schwann cells prolifer-et al., 2000), we hypothesized that Ski expression might
ate as part of Wallerian degeneration (Figure 4C, com-be inhibited in TGF-1-treated DRG-Schwann cell co-
pare lanes 2 and 3). Two months after crush injurycultures under myelinating conditions. Indeed, we found
(2mpC), when axons have regenerated and remyelin-that TGF-1 efficiently blocked myelination induced by
ated, the expression of Ski reached similar levels as inascorbic acid/progesterone (Figures 3Ac and 3Af, red)
uninjured samples (Figure 4D, compare lanes 1 and 2).and prevented Ski expression (Figures 3Ac and 3Af,
In contrast, 2 months after nerve transection (2mpT) andgreen).
prevention of regeneration, Ski protein levels remained
low (Figure 4D, compare lanes 1 and 3).
Ski Is Expressed by Myelinating Schwann Cells To corroborate the biochemical studies, the subcellu-
In Vivo and Is Regulated by Axon-Schwann lar localization of Ski protein on teased sciatic nerve
Cell Interactions fibers was examined (Figures 4E). In adult animals, Ski
To further examine the role of Ski in the regulation of (Figure 4Ea, green) was readily detected in nuclei (Figure
Schwann cell proliferation and differentiation, we inves- 4E, arrowheads in 4Ea and 4Eb) of myelinating Schwann
tigated the expression of Ski in vivo during postnatal cells as visualized by staining for myelin basic protein
PNS development and before and after nerve injury (Fig- (MBP; Figure 4Eb, red). Four days after transection, Ski
ure 4). Using quantitative real-time reverse-transcriptase immunoreactivity was strongly reduced in the degener-
polymerase chain reaction (qRT-PCR), we detected no ating distal stump of sciatic nerves (Figures 4Ec and
significant changes in Ski mRNA levels in the nerves of 4Ed; Ski in green, Schwann cell marker S100 in red).
Taken together, these results indicate that Ski proteindeveloping animals at postnatal (P) days 1.5 to 23 (Figure
Ski in Schwann Cells
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Figure 4. Ski Expression in Schwann Cells In Vivo
(A) qRT-PCR was performed to determine Ski mRNA levels in sciatic nerves during postnatal development (P1.5–P64; gray bars). As internal
control for the integrity of the samples, mRNA levels of PMP22 were measured (black bars). cDNA from nerves of at least three animals was
generated per time point, except for p64, where two animals were used. Each bar represents the mean value of three independent PCR
experiments SD. Student’s t test was applied to test for significance. Results are presented as ratios of Ski or PMP22 to 18S rRNA and
normalized to the levels at P1.5. No significant changes in Ski expression were observed, whereas the levels of PMP22 were upregulated
during the myelination process as described (Suter et al., 1994).
(B) qRT-PCR was performed to study the abundance of Ski mRNA in adult uninjured and injured sciatic nerves (gray bars). PMP22 served as
internal control (black bars). cDNA from nerves of three animals per paradigm were generated. Each bar represents the mean value of three
PCR experiments SD. Student’s t test was applied to test for significance. Results are shown as ratios of Ski or PMP22 to 18S rRNA. No
significant changes in the levels of Ski transcripts were observed, whereas the levels of PMP22 were downregulated after nerve injury as
previously shown (Suter et al., 1994).
(C) Western blot analysis using nuclear extracts of developing (P0; lane 1), adult uninjured (P90; lane 2), and adult injured sciatic nerves 4
days posttransection (4dpT; lane 3). Membranes were incubated with a monoclonal anti-Ski antibody. Comparable loading of protein extracts
was controlled by -actin detection. Note the increase in Ski protein levels in adult versus developing nerves. Ski expression decreased
drastically 4dpT as Schwann cells proliferated (lane 3).
(D) Western blot analysis using sciatic nerve nuclear extracts of adult uninjured (lane 1), 2 months post-crush lesion (2mpC; lane 2), and 2
months posttransection (2mpT; lane 3) samples. Membranes were incubated with a monoclonal anti-Ski antibody. Ski levels return to normal
after a crush injury when axons are allowed to regenerate, but not when regeneration is inhibited by nerve transection. Equal loading of protein
extracts controlled by -actin detection.
(E) Triple labeling of a teased, uninjured, myelinated nerve fiber (Ea and Eb). Ski (green), DAPI (blue), and MBP (red). Arrowheads point to
nuclear staining of Ski. Triple labeling of a teased nerve fiber 4 days after nerve injury (Ec and Ed). Ski (green), DAPI (blue), and Schwann cell
marker S100 (red). Note the lack of Ski in Schwann cell nuclei after nerve injury (arrowheads). Scale bar, 40 m (in [Eb] for [Ea]–[Ed]).
levels are low in proliferating Schwann cells but high in Ski Is Not Expressed by Schwann Cells
of Demyelinated Peripheral Nervesmyelinating cells. This regulation involves posttranscrip-
tional mechanisms and neuron-Schwann cell interac- Our results described so far show that Ski is undetect-
able in proliferating Schwann cells in vitro and in vivo,tions.
Neuron
504
Figure 5. Ski Expression in Animal Models of Demyelinating Neuropathies
(A) Double labeling of teased sciatic nerves for Ski (green) and DAPI (blue) in wt (Aa–Ae), PMP22-deficient (PMP22/; [Af–Ai]), PMP22-
transgenic (PMP22Tg; [Aj and Ak]), and PMP22 Trembler (PMP22Tr; [Al and Am]) mice. In wt animals, Ski was highly expressed (Aa) and
localized to the nuclei (Ab) (arrowheads in [Aa] and [Ab]). Note that the double-positive nuclei appear greenish blue (Ab). Magnification of a
wt nucleus visualizing the nuclear Ski staining ([Ac], Ski; [Ad], DAPI; [Ae], overlay). In PMP22-deficient nerves, Ski was mainly absent from
the nuclei (arrowheads in [Af] and [Ag]) ([Af], Ski; [Ag], Ski/DAPI). Magnification of a nucleus from PMP22-deficient nerves demonstrating low
levels of nuclear Ski staining ([Ah], Ski; [Ai], Ski/DAPI). Ski is also absent in Schwann cell nuclei of PMP22-transgenic mice (arrowheads in
[Aj] and [Ak]) ([Aj], Ski; [Ak], Ski/DAPI) and Trembler animals (arrowheads in [Al] and [Am]) ([Al], Ski; [Am], Ski/DAPI). Scale bar, 40 m (in [Ag]
for [Aa], [Ab], [Af], and [Ag]), 10 m (in [Ai] for [Ac]–[Ae], [Ah], and [Ai]), and 20 m (in [Am] for [Aj]–[Am]).
(B) Western blot analysis of nuclear extracts from adult wt (lane 1) and PMP22-deficient (lane 2) sciatic nerves. The membrane was incubated
with a monoclonal anti-Ski antibody. Both lanes contain equal amounts of protein extract as controlled by -actin detection. Note the strong
downregulation of Ski in mutant animals.
i.e., during development or after nerve injury. Hence, Ski ated (Adlkofer et al., 1995). Immunoblot analysis con-
firmed that Ski levels were below the detection limit inappears to play an important role in regulating cell cycle
exit, Schwann cell differentiation, and, possibly, myelin- nerves of PMP22-deficient animals (Figure 5B). Thus,
Ski is not expressed by demyelinating Schwann cells.ation. We therefore examined Ski expression in another
clinically important and mechanistically different para-
digm in which Schwann cell proliferation and myelina- Ski Is Required for Myelination of Peripheral
Nerves and Regulates Myelin Gene Expressiontion are affected in vivo. In hereditary demyelinating
diseases such as Charcot-Marie-Tooth type 1 (CMT1), Since Ski expression is closely associated with myelina-
tion, we asked whether Ski is essential for Schwannboth Schwann cell proliferation and myelination are dis-
turbed (Atanasoski et al., 2002; Dyck et al., 1993; Sancho cells to produce myelin. To this end, we employed a
genetic approach using Ski-deficient mice. As these ani-et al., 1999, 2001; Suter and Scherer, 2003). In affected
nerves, repeated cycles of demyelination and remyelina- mals die perinatally (Berk et al., 1997), preventing us
from studying the postnatal event of PNS myelinationtion are associated with aberrant Schwann cell prolifera-
tion. In contrast to nerve lesions, however, there is no in vivo, we established DRG explant cultures under my-
elination-permissive conditions from mutant and wt ani-major acute damage to the axons, although axonal atro-
phy and loss are slowly developing features in CMT1 mals (Carenini et al., 1998). Myelination (Figure 6A, MBP,
red) was readily apparent in DRG cultures originating(Suter and Scherer, 2003). We examined sciatic nerves
of two authentic mouse models for CMT1A, the Trembler from wt (Ski/) animals (Figure 6Aa) but absent in Ski/
samples (Figure 6Ab). As underscored by the statisticaland the PMP22-transgenic mouse (Figure 5). The Trem-
bler mouse carries a point mutation in the peripheral analysis (Figure 6B), there is an absolute requirement
for Ski in the formation of PNS myelin.myelin protein 22 (PMP22; Suter et al., 1992), and
PMP22-transgenic mice carry additional copies of the Ski-mediated regulation of myelin-related genes is a
potential mechanism by which Ski may affect myelina-PMP22 gene (Magyar et al., 1996). In both mouse strains,
axons are largely devoid of myelin. We detected no Ski tion. Thus, we performed in situ hybridization experi-
ments on transverse sections from E19.5 embryos of wtexpression in Schwann cell nuclei (Figure 5A, arrow-
heads in 5Aj–5Am) of adult mutant animals in contrast and Ski-deficient mice (Figure 7). Ski/ mice express
the glial marker Sox10 (Figure 7A) and the myelin-relatedto wild-type (wt) mice (Figures 5Aa–5Ae, arrowheads in
5Aa and 5Ab). Similarly, Ski was mostly not detectable in genes MBP (Figure 7C), PMP22 (Figure 7E), and MPZ/
P0 (Figure 7G) in DRGs (arrows in Figures 7A, 7C, 7E,adult PMP22-deficient mouse nerves (Figures 5Af–5Ai,
arrowheads in 5Af and 5Ag), which are largely demyelin- and 7G) and peripheral nerves (arrowheads in Figures
Ski in Schwann Cells
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Figure 6. Absence of Myelin Formation in DRG Explants from Ski-
Deficient Animals
(A) MBP immunofluorescence in control ([Aa], Ski/) and mutant
([Ab], Ski/) DRG explant cultures grown in myelination-promoting
media. Note the complete absence of myelin in Ski-deficient
samples.
(B) Numbers of analyzed DRG cultures of Ski/ (19) and Ski/
(15) animals (black bars). Seventeen control Ski/ samples showed
MBP-positive internodes, whereas no MPB staining was detected
in Ski/ DRG cultures (gray bars).
Figure 7. In Situ Hybridization Analysis of Glial and Neuronal Mark-
ers on Transverse Sections of E19.5 Embryos
7A, 7C, 7E, and 7G). In addition, Sox10 and MBP are The glial marker Sox10 (A and B) showed no difference in expression
also detected in oligodendrocytes (open arrowheads in mutant ([B], Ski/) versus wt ([A], Ski/) embryos. Expression of
MBP (C and D), PMP22 (E and F), and MPZ/P0 (G and H) in wt andin Figures 7A–7D). Mutant mice (Ski/) show a strong
Ski-deficient embryos revealed that all myelin gene-related markersreduction in the expression of the myelin-related genes
tested were strongly downregulated in the DRG (arrows) and periph-(Figures 7D, 7F, and 7H), both in peripheral nerves (ar-
eral nerves (arrowheads) of the mutant (D, F, and H) compared to
rowheads) and DRGs (arrows). This lower expression is control embryos (C, E, and G). Open arrowheads point to oligoden-
not due to reduced glia cell numbers, since Sox10 levels drocytes in control and mutant mice, which show no difference in
are unchanged in the mutants (Figure 7, compare 7A Sox10 (A and B) and MBP expression (C and D). Similarly, the neural
marker neurofilament (NF; [I and J]) showed no difference in expres-and 7B). In contrast to the PNS, MBP was not reduced in
sion in mutant (J) versus wt (I) embryos. Arrows (I and J) point tothe CNS of mutant animals (Figure 7D, open arrowhead).
the DRG, and the asterisk (I and J) marks neurons in the CNS. ScaleExpression of the neuronal marker neurofilament (NF;
bar, 40 m (in [J] for [A]–[J]).
Figures 7I and 7J) was also unaffected both in DRGs
(arrows) and the spinal cord (asterisk) of mutant mice.
We conclude that the absence of Ski specifically affects lected 3 days postinfection and processed for further
analysis. Compared to control EGFP-infected cells (Fig-the expression of myelin-related genes in the PNS, but
not in the CNS. ure 8A, gray bars), qRT-PCR experiments revealed an
3-fold induction of the myelin gene transcripts PMP22,To directly assess the influence of Ski on myelin gene
regulation, we infected primary Schwann cells with an MPZ/PO, and periaxin in Ski-infected Schwann cell cul-
tures (Figure 8A, black bars). This induction was alsoEGFP- or a Ski-expressing adenovirus. Cells were col-
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Figure 8. Ski Regulates Genes Related to
Myelination
(A) qRT-PCR was performed to study the
abundance of various myelin-related markers
(PMP22, MPZ/P0, and periaxin) in control
EGFP (gray bars) versus Ski-infected (black
bars) primary rat Schwann cells. cDNA from
three different cultures per paradigm were
generated. Each bar represents the mean
value of three independent PCR experiments
SD. Student’s t test was applied to test for
significance: **p  0.01. Values of control-
infected samples arbitrarily set to 1. All tested
myelin-related molecules were significantly
upregulated by Ski overexpression.
(B) Western blot analysis of extracts from
control EGFP (lane 1) versus Ski-infected
(lane 2) primary Schwann cells showed a
3-fold induction in periaxin levels upon Ski
overexpression (arrow). Extracts of myelinat-
ing DRG explant cultures were used as a posi-
tive control (lane 3). Both lanes contain similar
amounts of protein extract as verified by
-actin detection. Open arrowhead indicates
unspecific bands.
(C) Western blot analysis of Oct6 and Krox20
expression in control EGFP (lane 1) and Ski-
infected (lane 2) primary rat Schwann cells.
Comparable loading of protein extract con-
trolled by -actin detection. Schwann cells
overexpressing Oct6 or Krox20 were used as
positive controls (lane 3). Note the upregula-
tion of Oct6 upon Ski infection.
(D) Western blot analysis of Ski expression in
control EGFP (lane 1) and Oct6-transfected
(lane 2) primary rat Schwann cells. Mem-
branes were incubated with polyclonal anti-
bodies against Ski or Oct6, showing an
2-fold upregulation of Ski as a result of Oct6
overexpression (lane 2). In contrast, Ski pro-
tein levels remained the same in control EGFP
(lane 3) and Krox20-infected (lane 4) primary
rat Schwann cells. Membranes were incu-
bated with polyclonal antibodies against Ski
or Krox20. Similar loading controlled by
-actin detection.
(E) Western blot analysis of sciatic nerve extracts of control (Oct6/SCE; lane 1) and mutant animals carrying Schwann cell-specific Oct6
hypomorphic alleles (Oct6SCE/SCE; lane 2). The membrane was incubated with monoclonal antibodies against Ski. Comparable protein loading
confirmed by -actin detection. Note the 10-fold reduction of Ski expression in mutant versus control animals.
(F) Western blot analysis of Oct6 expression in control (lane 1) and p21-infected (lane 2) primary rat Schwann cells. Membranes were incubated
with polyclonal antibodies against Oct6. Schwann cells overexpressing Oct6 were used as positive control (lane 3). Comparable loading of
protein extract controlled by -actin detection.
(G) Western blot analysis of p21 expression in control (lane 1) and Ski-infected (lane 2) primary rat Schwann cells. Membranes were incubated
with polyclonal antibodies against p21, showing upregulation of p21 as a result of Ski overexpression (lane 2). Schwann cells overexpressing
p21 were used as positive control (lane 3). Similar loading controlled by -actin detection.
reflected at the protein level, as Western blot analysis Western blot analysis revealed that Oct6 was upregu-
lated in Schwann cells overexpressing Ski (Figure 8C,revealed an 3-fold induction in periaxin protein upon
Ski overexpression (Figure 8B, lanes 1 and 2). lane 2, upper panel) compared to control EGFP-infected
cells (Figure 8C, lane 1, upper panel). In contrast, Krox20
was barely detectable in EGFP-infected and in Ski-over-Ski Modulates the Expression of Oct6,
and Schwann Cells Deficient in Oct6 expressing Schwann cells (Figure 8C, lanes 1 and 2,
middle panel). Next, we examined whether Oct6 andShow Decreased Levels of Ski
We hypothesized that the observed functional role of Krox20 influence the expression of Ski. Primary Schwann
cells transfected with an Oct6 expression plasmidSki in Schwann cells might be related to the regulation
of Oct6 and Krox20 since these transcription factors showed an2-fold increase in Ski protein levels (Figure
8D, lane 2, upper panel) compared to control EGFP-are crucially involved in the control of Schwann cell
differentiation. To approach this question, cultured transfected cells (Figure 8D, lane 1, upper panel).
Krox20-overexpressing Schwann cells showed no dif-Schwann cell were infected with EGFP- or Ski-express-
ing adenovirus, and cells were collected 3 days later. ference in Ski expression levels (Figure 8D, lane 4, upper
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panel) in comparison to EGFP-infected cells (Figure 8D, Ski is likely to be involved in the regulation of a wide
range of cellular functions and developmental pro-lane 3, upper panel). In summary, Ski and Oct6 appear
to mutually regulate each other, while Krox20 is not cesses. Consistent with an antagonistic role of Ski in
the TGF- pathway, Ski overexpression in our studyaffected by Ski overexpression or vice versa.
Based on the observed functional interplay between repressed specifically TGF-1-mediated Schwann cell
proliferation but had no effect on GGF and bFGF-medi-Ski and Oct6 in gain-of-function experiments, we further
tested this mechanism in a loss-of-function paradigm ated cell division. In further support of this hypothesis,
Ski and Smad2/3 can be coimmunoprecipitated fromin Schwann cells lacking Oct6. Western blot analysis of
nerve extracts from adult animals carrying Schwann confluent Schwann cells cultured with TGF-1 (data not
shown). In contrast, when Ski was overexpressed incell-specific Oct6 hypomorphic alleles (Oct6SCE/SCE;
Ghazvini et al., 2002) and controls demonstrated an growth-arrested Schwann cells, GGF and bFGF, like
TGF-1, were unable to trigger the reentry into the cell10-fold reduction of Ski expression in the absence of
Oct6 (Figure 8E, compare lanes 1 and 2). These results cycle. Thus, the effect of Ski appears to be dependent
on the extracellular environment as well as on the growthcorroborate our findings of a functional interplay be-
tween Ski and Oct6 and suggest that Schwann cell dif- and differentiation status of the cell (Engert et al., 1995;
Ichikawa et al., 1997). A similar differential behavior hasferentiation involves Oct6-mediated activation of Ski.
been observed in quail embryo fibroblasts where Ski
can induce both oncogenic transformation and terminalSki Links Growth Arrest and Differentiation
muscle differentiation, depending on the growth condi-in Schwann Cells
tions (Colmenares and Stavnezer, 1989). The results alsoGrowth arrest and differentiation are tightly coupled dur-
suggest that Ski probably not only acts through the TGF-ing postnatal Schwann cell development. Based on our
pathway and Smads in Schwann cells—interactions withdata, we therefore asked whether Ski was triggering
other Ski partners, including the retinoic acid receptorthe differentiation program as a default consequence of
(RAR), Gli3, retinoblastoma protein, Skip, C184M, andinhibiting proliferation. To test this possibility, the cell
NFI may also be involved (Dahl et al., 1998a, 1998b; Daicycle inhibitor p21 (Sherr, 1995) was overexpressed in
et al., 2002; Kokura et al., 2003; Tarapore et al., 1997;Schwann cells, causing efficient growth arrest (data not
Tokitou et al., 1999).shown). Oct6 was not induced by exogenous p21 (Figure
As expected for an antagonistic role of Ski in TGF-8F, lanes 1 and 2), similar to the myelin-related genes
signaling, Ski protein was not expressed in myelin-com-PMP22, MPZ/P0, and periaxin (data not shown). Con-
petent cocultures of sensory neurons and Schwann cellsversely, to determine whether Ski-mediated growth ar-
in the presence of TGF-1, conditions that inhibit myelin-rest involves p21, Schwann cell cultures were infected
ation. In the absence of TGF-1, however, Ski proteinwith EGFP or Ski-expressing adenovirus and analyzed
levels were high in Schwann cells in cocultures, regard-by immunoblots (Figure 8G). p21 was upregulated in
less of whether the Schwann cells were myelinating orSchwann cells overexpressing Ski. We conclude that
not. Intriguingly, this upregulation was not observed inSki does not induce differentiation merely by stopping
pure Schwann cell cultures in the same medium. Thus,Schwann cell proliferation but plays an active role in
yet unidentified factors produced by neurons underboth the regulation of Schwann cell growth arrest and
these myelin-inducing conditions regulate Ski proteinmyelination.
expression in Schwann cells.
Germline inactivation of Ski in mice causes perinatalDiscussion
lethality and decreased precursor cell numbers in the
neuroepithelial and skeletal muscle lineages, in additionIn this report, we show that the protooncogene Ski plays
to other abnormalities (Berk et al., 1997). We found thata crucial role in the control of Schwann cell proliferation
loss of Ski prevents myelination in organotypic DRGand peripheral nerve myelination. This conclusion is
cultures, indicating that Ski expression is required forbased on multiple lines of in vitro and in vivo evidence.
peripheral nerve myelination. Since Schwann cell prolif-First, Ski expression is inversely correlated with Schwann
eration and myelination are dependent on axon-Schwanncell proliferation both in vitro and in vivo. Second, Ski
cell interactions, this raises the question of which celloverexpression causes growth arrest in Schwann cells
type is mainly dependent on Ski expression. In this re-that are cultured in the presence of TGF-1. Third, Ski
gard, we found that overexpression of Ski in culturedprotein expression is upregulated in myelinating Schwann
Schwann cells causes upregulation of myelin proteincells, and organotypic DRG cultures derived from Ski-
genes and of the regulator Oct6. Conversely, transcriptdeficient mice are unable to form myelin. Fourth, Ski
levels of myelin protein genes were reduced in Ski-defi-regulates genes encoding myelin proteins and Oct6, a
cient peripheral nerves in late embryonic development.major regulator of PNS myelination. Finally, Ski links the
Together, these findings indicate a major regulatorytwo biologically interconnected events of cell cycle exit
function for Ski in myelin protein gene regulation andand differentiation in Schwann cells.
Schwann cell differentiation. However, Ski is also ex-Ski exerts its functions in concert with various intracel-
pressed by motor and sensory neurons (Lyons et al.,lular partners, including the Smad proteins (Akiyoshi et
1994; data not shown). Ski-deficient DRG culturesal., 1999; Luo et al., 1999; Sun et al., 1999; Wu et al.,
showed some transient delay in initial neurite outgrowth2002; Xu et al., 2000) that are mediators of the TGF-
(data not shown) that may also indicate some role of Skireceptor signal transduction (Shi et al., 1997, 1998).
in neurons. To examine for early developmental defectsBinding of Ski to Smads represses their ability to activate
target genes of TGF- family signaling. In this manner, with respect to axonal outgrowth, we analyzed E19.5
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on glass coverslips (Carenini et al., 1998). Cultures were maintainedSki-mutant peripheral nerves by electron microscopy
in myelination-promoting medium for up to 3 weeks.but found no gross abnormalities (data not shown).
DRG-Schwann cell cocultures were established as describedSki induces Oct6 expression in cultured Schwann
(Notterpek et al., 1999). Where indicated, TGF-1 was added to the
cells, and Oct6 also upregulates Ski. In addition, Oct6- myelination-promoting medium to a final concentration of 10 ng/ml.
deficient Schwann cells express Ski at much lower levels
than wt Schwann cells. These findings indicate that Ski Ski Adenovirus Generation and Production
and Oct6 act in concert to control the Schwann cell To construct a Ski adenovirus, an internal ribosome entry site (IRES)
along with the GFPq (Quantum Biotechnology) gene was subcloneddifferentiation program. The corresponding mechanisms,
in the pShuttle-CMV plasmid (Mosser et al., 1997). The human Skihowever, remain to be clarified. One might speculate,
open reading frame was then inserted between the CMV promoterfor example, that the delay in myelination observed in
and the IRES leading to a CMV-driven cassette expressing both
Oct6-deficient mice is related to this interplay. Experi- Ski and GFP, whereas the control vector expresses GFP alone.
ments including overexpression of Ski in Oct6-deficient Recombinant adenoviruses were generated with the AdEasy system
Schwann cells to potentially rescue the developmental (Stratagene). The resulting adenoviral vector was amplified in
HEK293 cells, purified (BD Adeno-X Virus Purification Kit [Clontech]),delay phenotype will shed more light on this interest-
and stored in elution buffer.ing issue.
Induction of Schwann cell growth arrest by Ski over-
Transient Transfection and Infection of Schwann Cellsexpression is accompanied by the upregulation of my-
with Recombinant Adenovirus Vectors
elin-related genes. This might be interpreted so that Rat Schwann cells were grown at a density of 8000 cells/cm2 on
Schwann cell differentiation is caused directly as a con- laminin-2-coated dishes in Schwann cell medium. Fugene 6 (Roche)-
sequence of the effect of Ski on growth arrest. However, mediated transfection of human Ski (Xu et al., 2000) or EGFP expres-
sion plasmids (kind gift from B. Amati, ISREC, Lausanne) was per-we found that overexpression of the cell cycle inhibitor
formed at a ratio of 1.5 l Fugene/g plasmid DNA. BrdU labelingp21 (Sherr, 1995) induced only growth arrest but no
and detection was carried out according to the manufacturer’s in-upregulation of myelin-related genes. Since Ski can also
structions (Roche).
induce growth arrest through p21, it is likely that Ski Primary rat Schwann cells were isolated and maintained in
is independently required for both growth arrest and Schwann cell medium. The following day, cells were either trans-
differentiation. We anticipate that identifying additional fected with expression plasmids using Fugene 6 or infected with
the indicated adenovirus. Fugene 6-mediated transfection of Oct6target genes of Ski will elucidate the mechanisms by
expression plasmid (Meijer et al., 1992) and infection with Krox20/which Ski is coupling the biologically interconnected
Egr2 (Ehrengruber et al., 2000) or ADV-p21 (Yang et al., 1996) adeno-events of proliferation and differentiation in postnatal
virus were performed as described. Adenovirus vectors were used
Schwann cell development. at m.o.i. of 1000. Twenty-four hours later, the medium was changed
In summary, our data show that Ski is necessary for and the cells maintained in Schwann cell medium for another 2
peripheral nerve myelination and is a major regulator days before analysis. Transfection and infection experiments were
repeated at least twice to insure the reproducibility of the results.of Schwann cell proliferation and differentiation. Future
conditional and cell-type specific Ski knockout experi-
Immunofluorescence Microscopyments will further define the specific roles of Ski in
Longitudinal nerve sections and teased fibers were blocked for 1Schwann cells and, potentially, neurons.
hr in PBS containing 10% goat serum, 1% BSA, and 0.3% Triton
X-100. Incubation with primary antibodies was carried out for 16
Experimental Procedures hr at 4C. Rat monoclonal antibodies against MBP (1:50 dilution;
Serotec) and Ki-67 (1:20; DAKO), mouse monoclonal antibodies
Animals against Ski (G8, 1:20; Colmenares et al., 1991), and rabbit polyclonal
Animal experiments (Wistar rats and C57bl/6 mice; Elevage Janvier, antibodies against S100 (1:300; DAKO) were used. For MBP staining,
France) were approved by the veterinary office of the Canton of nerve fibers were permeabilized with 100% Triton X-100 for 40 min
Zurich. Mutant mice: Schwann cell-specific Oct6 null mice (Ghazvini and organotypic DRG cultures with 5% Triton X-100 for 15 min at
et al., 2002), PMP22-deficient animals (Adlkofer et al., 1995), Trem- room temperature prior to the blocking step. After incubation with
bler mice (Suter et al., 1992), PMP22-transgenic mice (Magyar et the primary antibody, the tissue samples or fixed cells were washed
al., 1996), and mice deficient in Ski (Berk et al., 1997; Colmenares and exposed to the appropriate donkey anti-rat Cy3 (1:200), goat
et al., 2002). anti-rat Texas red (1:200), goat anti-mouse FITC (1:100), or goat anti-
rabbit Cy3 (1:200) secondary antibodies (Jackson ImmunoResearch
Sciatic Nerve Injuries and Preparation of Teased Fibers Laboratories, Inc.). Appropriate controls including secondary anti-
and Cryosections bodies showed no significant stainings. Note that anti-mouse IgG
Injuries and further processing were carried out as described (Atana- antibodies showed a diffuse overall background staining on mouse
soski et al., 2001). tissue. Finally, specimens were washed and mounted in AF1 (Citi-
fluor, Canterbury, UK) supplemented with DAPI (1:1000; Roche).
Immunoreactivity was visualized by fluorescence microscopy andCell Culture
Rat Schwann cells were grown in Schwann cell medium (Dulbecco’s documented using a Hamamatsu color chilled 3CCD camera. Pic-
tures were processed with Adobe Photoshop 7.0 for Macintosh.modified Eagle’s medium [DMEM], GIBCO BRL), containing 10%
FCS, 50 g/ml gentamicin (Sigma), 100 g/ml crude GGF (BioReba Rat Schwann cell cultures and Schwann cell/DRG cocultures were
fixed in 3.7% formaldehyde for 10 min at room temperature. Cocul-Biotechnology Inc.), and 2M forskolin (Sigma) as described (Atana-
soski et al., 2001). For growth arrest, cells were incubated for 3 days tures were additionally postfixed and permeabilized in 100% metha-
nol at 20C for 5 min. Unspecific binding was blocked for at leastin minimal medium plus 0.5% FCS. Minimal medium: DMEM/F12
(GIBCO), human apo-transferrin (100 g/ml), progesterone (60 ng/ 30 min in PBS containing 10% goat serum, 1% BSA, and 0.3%
Triton X-100. Primary antibodies against Ski (1:100; Upstate Biotech-ml), insulin (5 g/ml), putrescine (16 g/ml), L-thyroxin (400 ng/ml),
selenium (160 ng/ml), triiodothyronine (10 ng/ml), and 300g/ml BSA nology), Ki-67 (1:10; DAKO), MBP (1:500; Roche), MAG (1:1000; gift
of M.B.Tropak, S.Lunenfeld Research Institute, Toronto, Canada),(Fluka). Supplements were from Sigma, unless stated otherwise.
Schwann cell growth factors: human recombinant GGF (20 ng/ml), and p75 (1:300; Chemicon) were incubated in blocking buffer over-
night at 4C, followed by incubation with secondary antibodies inTGF-1 (10 ng/ml; R&D Systems), and bFGF (10 ng/ml; PeproTech).
For DRG explant cultures, DRGs were excised (E19.5) and plated blocking buffer for 1 hr at room temperature. BrdU labeling and
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detection was carried out according to the manufacturer’s instruc- for antibodies. We are grateful to Drs. Mark Marchionni for recombi-
nant GGF; Elizabeth Nabel for recombinant p21 adenovirus; andtions (Roche). After washing in PBS, cells were mounted in AF1
supplemented with DAPI (1:1000; Roche). Ned Mantei for comments on the manuscript. Katja Wichmann, Joke
Nowitzki, Lucilla Nobbio, and Dr. Regula Frei provided much ap-
preciated technical assistance. This work was supported by grantsWestern Blotting
from the National Muscular Dystrophy Association and the NIH-Sciatic nerve tissue was dissected, frozen in liquid nitrogen, pulver-
NINDS (to L.N.), the Kommission Inovative Forschung of the Univer-ized with a chilled mortar and pestle, and nuclear extracts were
sity of Mu¨nster (YO1021 to P.Y.), the Swiss National Science Founda-prepared (Atanasoski et al., 1997). Alternatively, cells were har-
tion, the Swiss Muscle Disease Foundation, and the NCCR Neuralvested and lysed in SDS gel sample buffer (Atanasoski et al., 2001).
Plasticity and Repair (to S.A., L.S., and U.S.), and by NIH grantsProteins were electophoresed on 7.5% SDS-polyacrylamide gels,
CA43600 (to E.S.) and HD30728 (to C.C.).transferred onto polyvinylidene difluoride membrane, and immu-
noblotted with antibodies against Ski (Upstate Biotechnology;
Received: April 1, 20041:100), MAG (1:1000), Periaxin (gift of P. Brophy, University of Edin-
Revised: June 29, 2004burgh, UK; 1:100), Krox20 (BabCO; 1:100), Oct6 (Ghazvini et al.,
Accepted: July 28, 20042002; 1:100), p21 (Santa Cruz Biotechnology, Inc.; 1:1000), and
Published: August 18, 2004-actin (Sigma; 1:1000). After incubating with goat anti-rabbit horse-
radish peroxidase- (Santa Cruz Biotechnology, Inc.) or goat anti-
mouse 	 chain alkaline phosphatase-conjugated secondary anti- References
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